Class Action Lawsuit Filed Against Sensa Weight Loss System
A settlement has been reached in the class action against Sensa® Weight Loss dietary supplement, and consumers may be entitled to compensation.
The class action against Sensa alleged that Sensa’s advertising claims were false, deceptive and misleading. Sensa claimed that it was a weight loss drug which would curb the appetite by controlling the taste and smell receptors. According to Sensa’s advertising, as a person eats, receptors send messages to the brain telling the body to stop eating. Plaintiffs alleged that Sensa® did not conduct sufficient scientific studies to support their marketing claims. Although Sensa® asserted they did conduct some scientific studies, the company elected to settle the claim.
The settlement that has been reached will provide up to $6,000,000 in compensation for the victims. This settlement is subject to court approval which is set to take place on November 7, 2012 at 10:30am, Department 309 at the Los Angeles County Superior Court located at 600 South Commonwealth Avenue, Los Angeles, CA 90005.
Unfortunately, the class action against Sensa is not an isolated incident of claims being brought against dietary supplements for false and deceptive advertising. Recently, in January, 2012, dietary supplement company, Iovate Health Sciences, was forced to pay $1.5 million dollars to settle claims brought by ten different California counties for deceptive advertising.
Dietary supplement not only spread misleading advertising – they can also be extremely harmful. Over the past decade, a number of consumers believe they have alleged to have been physically injured by taking dietary supplement, some of which have prompted recalls. In 2004, for example, Ephedra was banned from the market for causing unacceptable health risks. In 2009, another dietary supplement, several brands of Hydroxycut were voluntarily recalled by its manufacturer for causing liver toxicity.
If you or a loved one has been misled or injured by a dietary supplement, please contact Khorrami, LLP for a confidential communication.